Originator vs Generic Medicines: What Actually Differs

Originator and generic medicines contain the same active ingredient, yet they differ in how they reach the market, what evidence stands behind them and what they cost. For anyone working with drug data, knowing where the difference lies, and where it does not, matters for substitution, pricing and market access.

The originator: a full dossier

An originator medicine, in German Originalpraeparat, is the first product to bring an active ingredient to market. Its approval rests on a complete dossier, including the preclinical and clinical trials that establish efficacy and safety. That investment is protected for a period by patent and a supplementary protection certificate.

The generic: same effect, proven by bioequivalence

A generic, Generikum, enters once that protection expires. It does not repeat the full clinical programme. Instead it demonstrates bioequivalence to the reference product: regulators require that the key pharmacokinetic parameters fall within an accepted range of the originator, so that the two are therapeutically interchangeable. Same active ingredient, same strength and dosage form, comparable behaviour in the body, usually a markedly lower price.

Where the difference is real, and where it is not

• Active ingredient and effect: equivalent by regulatory requirement.
• Excipients, shape and appearance: can differ, which occasionally matters for tolerability or identification.
• Price and reimbursement: the main practical difference, driven by fixed amounts and rebate contracts.

Biological medicines are a separate case. A follow-on biologic is not a generic but a biosimilar, because biologics cannot be copied identically. See our glossary on the Originalpraeparat and the Generikum.

Why this is a data question

In practice the choice between originator and generic at the counter is governed by aut idem and by which product is under contract. Reliable master, price and reimbursement data per PZN is what lets pharmacies substitute correctly and lets manufacturers and market access teams see the competitive picture. pharmazie.com brings these data sources together in one search.